Markets & Regulations

(metamorworks/iStock via Getty Images Plus)

Tech Innovations: September 2021

By Jenni Spinner

This month’s roundup of new technology, equipment, and industry partnerships includes news from IBM, IQVIA, Mediata, Labcorp, and other notable companies.

(Eoneren/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The US agency continues to oversee vaccine and drug development, and to share information and advice for life-sciences professionals and civilians alike.

(alengo/iStock via Getty Images Plus)

People on the Move: September 2021

By Jenni Spinner

This month’s news on new hires, board launches, acquisitions, and other important news includes items on Pfizer, Javara, Clinical Ink, and other companies.

(Jonathan Kitchen/iStock via Getty Images Plus)

Latest COVID-19 updates from the FDA

By Jenni Spinner

The US Food and Drug Administration continues to review potential preventatives and treatments for the virus, and to offer advice to life-sciences professionals and civilians alike.

(suedhang/iStock via Getty Images Plus)

People on the Move: August 2021

By Jenni Spinner

This month’s news on hires, promotions, acquisitions, expansions, and funding includes items about Syneos Health, ProSciento, Phastar, CPhI, Immunai, and other key industry players.

(Andrew Brookes/iStock via Getty Images Plus)

Tech Innovations: July 2021

By Jenni Spinner

This month’s roundup of new excipients, manufacturing sites, partnerships, and other items includes news from DFE Pharma, Vetter, and other notable firms.

© GettyImages/DNY59

FDA lead calls for independent inquiry into Biogen drug approval

By Jane Byrne

Acting US FDA commissioner, Janet Woodcock, has called for an independent federal review of interactions between officials at her agency and representatives of Biogen, prior to the recent approval of the pharma company’s treatment for Alzheimer’s disease....

(mikkelwilliam/iStock via Getty Images Plus)

People on the Move: July 2021

By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

(Thaweesak Saengngoen/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The agency has been busy with actions related to the virus behind the pandemic, keeping an eye on vaccinations, emerging variants, and other concerns.

(Who_I_am/iStock via Getty Images Plus)

Tech Innovations: June 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

Pic:getty/CG6images

FDA approves Biogen’s Alzheimer's drug, Aduhelm

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s: making it the first new treatment approved for the disease since 2003.

Follow us

Products

View more

Webinars